| ARCHETYPE ID | openEHR-EHR-CLUSTER.lab_antigen.v0 |
|---|---|
| Concept | Antigen test finding |
| Description | The result of a laboratory test designed to directly identify and measure the presence of a specific antigen, typically associated with a microorganism, tissue, or physiological process, within a clinical specimen. |
| Use | Use to record the qualitative and quantitative findings for a specific antigen test for microbial and non-microbial antigens. |
| Misuse | Not to be used to record findings observed from microbial culture of a specimen - use the CLUSTER.laboratory_test_culture archetype for this purpose. Not to be used to record findings from antibody testing of a specimen - use the CLUSTER.laboratory_test_antibody archetype for this purpose. Not to be used to record findings from molecular testing of a specimen - use the CLUSTER.laboratory_test_molecular archetype for this purpose. |
| Purpose | To record the qualitative and quantitative findings for a specific antigen test. |
| References | |
| Copyright | © openEHR Foundation, Ministry of Health and Wellness Jamaica |
| Authors | Author name: Heather Leslie Organisation: Atomica Informatics Email: heather.leslie@atomicainformatics.com Date originally authored: 2024-08-09 |
| Other Details Language | Author name: Heather Leslie Organisation: Atomica Informatics Email: heather.leslie@atomicainformatics.com Date originally authored: 2024-08-09 |
| Other Details (Language Independent) |
|
| Keywords | |
| Lifecycle | in_development |
| UID | a36e25fa-1e38-41a5-9753-80944670bd77 |
| Language used | en |
| Citeable Identifier | 1013.1.7643 |
| Revision Number | 0.0.1-alpha |
| items | |
| Test name | Test name: Name of the antigen test. Coding with an external terminology is recommended, if available. For example: SARS-CoV-2 rapid antigen test, HIV p24 Antigen ELISA, PSA chemiluminescent immunoassay, AFP ELISA, HER2/neu immunohistochemistry (IHC) test. |
| Antigen target | Antigen target: The specific antigenic or protein structure or component that the test is designed to detect. Coding with an external terminology is recommended, if available. For example: spike protein (SARS-CoV-2), nucleocapsid protein (SARS-CoV-2), capsid protein (HIV), lipopolysaccharides (LPS) in gram-negative bacteria, prostate-specific antigen (PSA), alpha-fetoprotein (AFP), carcinoembryonic antigen (CEA), HER2/neu, CA-125. |
| Microbial target | Microbial target: The name of the microorganism associated with the antigen, if relevant. Coding with an external terminology is recommended, if available. For example: SARS-CoV-2, HIV. |
| Test method | Test method: Method used for the antigen test. Coding with an external terminology is recommended, if available. For example: lateral flow immunoassay, ELISA, immunohistochemistry (IHC). |
| Specimen | Specimen: Identification of the specimen examined. If the tissue specimen has previously been identified in a a higher level archetype level archetype, such as the OBSERVATION.laboratory_test_result, this SLOT may be redundant. Include: All not explicitly excluded archetypes |
| Presence | Presence: Statement about detection of the identified antigen in the specimen.
|
| Quantitative result | Quantitative result: Quantitative assessment of the amount of the identified antigen in the specimen. Units:
|
| Comment | Comment: Additional narrative about the test finding not captured in other fields. |
| Other contributors | Nicola Ewen, SERHA/Ministry of Health and Wellness, Jamaica Heather Leslie, Atomica Informatics, Australia (openEHR Editor) Yohann White, Ministry of Health and Wellness, Jamaica |
| Translators |